[home]
[thesaurus]
Click Here to return To Results
Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008
See this aricle in Pubmed
Article Abstract
No abstract available for this article
Related Tags
(click to filter results - removes previous filter)
adverse drug reaction
complications
drug withdrawal
iatrogenic neurologic disorders
monoclonal antibodies
MRI
MRI,abnormal
multiple sclerosis
multiple sclerosis,treatment of
natalizumab
treatment of neurologic disorder
Click Here to return To Results